Cytori Therapeutics reported $1.06M in Selling and Administration Expenses for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Baxter International BAX:US $ 600M 46M
Cytori Therapeutics CYTX:US $ 1.06M 369K
Dr.Reddys Laboratories DRRD:IN 21.68B 711M
Genocea Biosciences GNCA:US $ 3.88M 397K
Haemonetics HAE:US $ 73.49M 2.16M
Infinity Pharmaceuticals INFI:US 2.93M 7K
Mirati Therapeutics MRTX:US $ 25.34M 5.09M
Sun Pharmaceuticals SUNP:IN 17.2B 151.6M
Sunesis Pharmaceuticals SNSS:US $ 2.32M 251K
Teva Pharmaceutical TEVA:IT 965M 112M